Locally administrated perindopril improves healing in an ovariectomized rat tibial osteotomy model

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Zhao, Xiong ^a   Wu, Zi xiang ^a   Zhang, Yang ^a   Gao, Ming xuan ^a   Yan, Ya bo ^a   Cao, Peng chong ^a   Zang, Yuan ^a   Lei, Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; CALLUS; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; FRACTURE FIXATION; FRACTURE HEALING; INTRAMEDULLARY NAILING; NONHUMAN; OSSIFICATION; OVARIECTOMY; RAT; TIBIA FRACTURE; TIBIA OSTEOTOMY; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT BEARING; ANALYSIS OF VARIANCE; ANIMAL; BONE DEVELOPMENT; DRUG EFFECT; MICRO-COMPUTED TOMOGRAPHY; OSTEOTOMY; SPRAGUE DAWLEY RAT; TIBIA; ULTRASTRUCTURE; WOUND HEALING;

RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; BIOMECHANICS; BONY CALLUS; FEMALE; OSTEOGENESIS; OSTEOTOMY; OVARIECTOMY; PERINDOPRIL; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; WEIGHT-BEARING; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84863242804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033228     Document Type: Article

References (39)

1. Namkung-Matthai H, Appleyard R, Jansen J, Hao LJ, Maastricht S, et al. (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28: 80-86.
2. Garnero P, Delmas PD, (1997) Osteoporosis. Endocrinol Metab Clin North Am 26: 913-936.
3. Hans D, Fuerst T, Lang T, Majumdar S, Lu Y, et al. (1997) How can we measure bone quality? Baillieres Clin Rheumatol 11: 495-515.
4. Delgado-Martinez AD, Martinez ME, Carrascal MT, Rodriguez-Avial M, Munuera L, (1998) Effect of 25-OH-vitamin D on fracture healing in elderly rats. J Orthop Res 16: 650-653.
5. McCormack AP, Anderson PA, Tencer AF, (1993) Effect of controlled local release of sodium fluoride on bone formation: filling a defect in the proximal femoral cortex. J Orthop Res 11: 548-555.
6. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, et al. (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17: 2038-2047.
7. Cao Y, Mori S, Mashiba T, Westmore MS, Ma L, et al. (2002) Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 17: 2237-2246.
8. Peach MJ, (1977) Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370.
9. Dzau V, (2005) The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hypertens Suppl 23: S9-S17.
10. Ondetti MA, Rubin B, Cushman DW, (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196: 441-444.
11. Izu Y, Mizoguchi F, Kawamata A, Hayata T, Nakamoto T, et al. (2009) Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem 284: 4857-4864.
12. Hatton R, Stimpel M, Chambers TJ, (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152: 5-10.
13. Hiruma Y, Inoue A, Hirose S, Hagiwara H, (1997) Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae. Biochem Biophys Res Commun 230: 176-178.
14. Schurman SJ, Bergstrom WH, Shoemaker LR, Welch TR, (2004) Angiotensin II reduces calcium uptake into bone. Pediatr Nephrol 19: 33-35.
15. Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S, (1998) Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 156: 543-550.
16. Perez-Castrillon JL, Silva J, Justo I, Sanz A, Martin-Luquero M, et al. (2003) Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens 16: 453-459.
17. Rejnmark L, Vestergaard P, Mosekilde L, (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24: 581-589.
18. Garcia P, Schwenzer S, Slotta JE, Scheuer C, Tami AE, et al. (2010) Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation- role of a local renin-angiotensin system. Br J Pharmacol 159: 1672-1680.
19. Li YF, Luo E, Feng G, Zhu SS, Li JH, et al. (2009) Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int.
20. Wang JW, Xu SW, Yang DS, Lv RK, (2007) Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 18: 1641-1650.
21. Fu L, Tang T, Miao Y, Hao Y, Dai K, (2009) Effect of 1,25-dihydroxy vitamin D3 on fracture healing and bone remodeling in ovariectomized rat femora. Bone 44: 893-898.
22. Muller R, Ruegsegger P, (1997) Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud Health Technol Inform 40: 61-79.
23. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, et al. (2009) Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res 24: 196-208.
24. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, et al. (2007) Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903-1912.
25. Giannoudis P, Tzioupis C, Almalki T, Buckley R, (2007) Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38 (Suppl 1): S90-S99.
26. Hao YJ, Zhang G, Wang YS, Qin L, Hung WY, et al. (2007) Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 41: 631-638.
27. Kubo T, Shiga T, Hashimoto J, Yoshioka M, Honjo H, et al. (1999) Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet. J Steroid Biochem Mol Biol 68: 197-202.
28. Wang JW, Li W, Xu SW, Yang DS, Wang Y, et al. (2005) Osteoporosis influences the middle and late periods of fracture healing in a rat osteoporotic model. Chin J Traumatol 8: 111-116.
29. Haulica I, Bild W, Serban DN, (2005) Angiotensin peptides and their pleiotropic actions. J Renin Angiotensin Aldosterone Syst 6: 121-131.
30. Diez J, Panizo A, Hernandez M, Vega F, Sola I, et al. (1997) Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30: 1029-1034.
31. Bonnet F, Cao Z, Cooper ME, (2001) Apoptosis and angiotensin II: yet another renal regulatory system? Exp Nephrol 9: 295-300.
32. Odaka C, Mizuochi T, (2000) Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin Exp Immunol 121: 515-522.
33. Matsumoto N, Manabe H, Ochiai J, Fujita N, Takagi T, et al. (2003) An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity. Shock 19: 547-552.
34. Nagashima M, Sakai A, Uchida S, Tanaka S, Tanaka M, et al. (2005) Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 36: 502-511.
35. Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-Wuttke D, et al. (2010) Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat. Langenbecks Arch Surg 395: 163-172.
36. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, et al. (2010) Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25: 404-414.
37. Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, et al. (2009) Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res 32: 786-790.
38. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, et al. (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22: 2465-2475.
39. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, et al. (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24: 241-250.